New avenues for Parkinson’s disease therapeutics: disease-modifying strategies based on the gut microbiota M Lorente-Picón, A Laguna Biomolecules 11 (3), 433, 2021 | 48 | 2021 |
In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease M Gonzalez-Sepulveda, J Compte, T Cuadros, A Nicolau, ... Brain 146 (3), 1040-1052, 2023 | 12 | 2023 |
Activity of NADH‐and FADH2‐linked mitochondrial respiration are significantly decreased in two mice models of Parkinson’s disease J Soliz, ML Picón, HH Doucet-Beaupré, M Levesque, S Laouafa The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
Neuroprotective effect of stomatin-like protein 2 overexpression in A53T-a-synuclein parkinson disease mice model M Lorente Picon | 1 | 2020 |
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related multisystem neurodegenerative deficits A Laguna, N Peñuelas, M Gonzalez-Sepulveda, A Nicolau, S Arthaud, ... bioRxiv, 2023.08. 08.552400, 2023 | | 2023 |
SLP-2 modulated expression rescues mitochondrial function in alpha-synuclein neuropathology models MPC Rueda, G Gentile, A Zanon, A Lavdas, C Bolduc, ML Picón, ... International Congress of Parkinson’s Disease and Movement Disorders, 2023 | | 2023 |
Modulation of SLP-2 expression protects against alpha-synuclein neuropathology by mitigating mitochondrial dysfunction MP Castelo-Rueda, G Gentile, A Zanon, A Lavdas, C Bolduc, ML Picón, ... Cell Symposia: Multifaceted Mitochondria, 2022 | | 2022 |
SLP-2 protects SNpc DA neurons against alpba-synuclein toxicity by rescuing mitochondrial functions in a mouse model of Parkinson's disease C Bolduc, ML Picon, S Laouafa, J Soliz, G Gentile, MP Castelo-Rueda, ... Keystone Symposia, 2022 | | 2022 |
Age-dependent multisystem parkinsonian features in a novel neuromelanin-producing transgenic mouse model N Peñuelas, A Laguna, M González-Sepúlveda, L Miquel-Rio, H Xicoy, ... | | 2021 |
Validation of the Neuroprotective Potential of SLP-2 against alpha-synuclein neuropathology in a Mouse Model of Parkinson's Disease C Bolduc, ML Picon, S Laouafa, J Soliz, I Pichler, M Levesque MOVEMENT DISORDERS 36, S204-S204, 2021 | | 2021 |
NEUROPROTECTIVE EFFECT OF STOMATIN-LIKE PROTEIN 2 OVEREXPRESSION IN A53T-α-SYNUCLEIN PARKINSON’S DISEASE MICE MODEL M Lorente-Picon, H Doucet-Beaupré, A Zanon, S Meschini, M Parent, ... 5th World Parkinson Congress, 2019 | | 2019 |